{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:30:32Z","timestamp":1785256232237,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yrtph.2019.104499","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T11:47:34Z","timestamp":1571140054000},"page":"104499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Tetrahydrofuran-induced tumors in rodents are not relevant to humans: Quantitative weight of evidence analysis of mode of action information does not support classification of tetrahydrofuran as a possible human carcinogen"],"prefix":"10.1016","volume":"109","author":[{"given":"Wolfgang","family":"Dekant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2019.104499_bib1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.yrtph.2019.104499_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-1110(91)90003-E","article-title":"Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP","volume":"257","author":"Ashby","year":"1991","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2019.104499_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yrtph.2015.04.004","article-title":"Increasing scientific confidence in adverse outcome pathways: application of tailored bradford-hill considerations for evaluating weight of evidence","volume":"72","author":"Becker","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yrtph.2017.02.017","article-title":"Quantitative weight of evidence to assess confidence in potential modes of action","volume":"86","author":"Becker","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib6","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/jat.3648","article-title":"Testing and refining the Science in Risk Assessment and Policy (SciRAP) web-based platform for evaluating the reliability and relevance of in vivo toxicity studies","volume":"38","author":"Beronius","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.yrtph.2015.04.018","article-title":"Modernizing problem formulation for risk assessment necessitates articulation of mode of action","volume":"72","author":"Borgert","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pa.30.040190.002025","article-title":"Biochemical mechanisms and pathobiology of alpha 2u-globulin nephropathy","volume":"30","author":"Borghoff","year":"1990","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2015.02.003","article-title":"Methyl isobutyl ketone exposure-related increases in specific measures of alpha2u-globulin (alpha2u) nephropathy in male rats along with in vitro evidence of reversible protein binding","volume":"333","author":"Borghoff","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2019.104499_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJM198209093071104","article-title":"Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease","volume":"307","author":"Brenner","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2019.104499_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10937404.2016.1200505","article-title":"Quantitative weight-of-evidence analysis of the persistence, bioaccumulation, toxicity, and potential for long-range transport of the cyclic volatile methyl siloxanes","volume":"19","author":"Bridges","year":"2016","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.yrtph.2019.104499_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yrtph.2010.04.009","article-title":"Histopathologic changes in the kidneys of male F344 rats from a 2-year inhalation carcinogenicity study of tetrahydrofuran: a pathology working group review and re-evaluation","volume":"58","author":"Bruner","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/toxsci\/41.2.183","article-title":"Carcinogenesis studies of tetrahydrofuran vapors in rats and mice","volume":"41","author":"Chhabra","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2019.104499_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.toxlet.2017.05.006","article-title":"Mode of action and human relevance of THF-induced mouse liver tumors","volume":"276","author":"Choi","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2019.104499_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0192623310363813","article-title":"Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary","volume":"38","author":"Cohen","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104499_bib16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.2204108","article-title":"Cell proliferation in carcinogenesis","volume":"249","author":"Cohen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2019.104499_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/taap.1999.8756","article-title":"Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice","volume":"160","author":"Constan","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yrtph.2016.09.009","article-title":"A quantitative weight of evidence methodology for the assessment of reproductive and developmental toxicity and its application for classification and labeling of chemicals","volume":"82","author":"Dekant","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1054-3589(08)60969-2","article-title":"Mechanisms of xenobiotic-induced renal carcinogenicity","volume":"23","author":"Dekant","year":"1992","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yrtph.2017.08.012","article-title":"A quantitative weight of evidence assessment of confidence in modes-of-action and their human relevance","volume":"90","author":"Dekant","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib22","series-title":"European Chemicals Agency (ECHA)\/Committee for Risk Assessment (RAC) Opinion Proposing Harmonised Classification and Labelling at Community Level of Tetrahydrofuran. ECHA\/RAC\/DOC No CLH-O-0000000954-69-03\/F Adopted on 25 May 2010","author":"ECHA-RAC","year":"2010"},{"key":"10.1016\/j.yrtph.2019.104499_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0773.1984.tb01921.x","article-title":"Burden and biochemical effects of extended tetrahydrofuran vapour inhalation of three concentration levels","volume":"54","author":"Elovaara","year":"1984","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib25","series-title":"Toxicological Review of Tetrahydrofuran (CAS No. 109-99-9) in in Support of Summary Information on the Integrated Risk Information System (IRIS)","year":"2012"},{"key":"10.1016\/j.yrtph.2019.104499_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2017.11.003","article-title":"Human relevance of rodent liver tumors: key insights from a Toxicology Forum workshop on nongenotoxic modes of action","volume":"92","author":"Felter","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yrtph.2011.01.009","article-title":"Assessing the human carcinogenic potential of tetrahydrofuran: I. Mode of action and human relevance analysis of the male rat kidney tumor. II. Mode of action and human relevance analysis of the female mouse liver tumor","volume":"60","author":"Fenner-Crisp","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib28","first-page":"329","article-title":"Evidence for the central role of glomerular growth promoters in the development of sclerosis","volume":"9","author":"Fogo","year":"1989","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.yrtph.2019.104499_bib29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/10408444.2013.836155","article-title":"A review of the toxicological and environmental hazards and risks of tetrahydrofuran","volume":"43","author":"Fowles","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/toxsci\/70.1.140","article-title":"Investigations on cell proliferation and enzyme induction in male rat kidney and female mouse liver caused by tetrahydrofuran","volume":"70","author":"Gamer","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2019.104499_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/rtph.1997.1161","article-title":"Chloroform mode of action: implications for cancer risk assessment","volume":"26","author":"Golden","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/019262339802600112","article-title":"Mechanisms of chemically induced renal carcinogenesis in the laboratory rodent","volume":"26","author":"Hard","year":"1998","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104499_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/toxsci\/69.1.30","article-title":"Significance of the renal effects of ethyl benzene in rodents for assessing human carcinogenic risk","volume":"69","author":"Hard","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2019.104499_bib34","series-title":"Expert Report on Renal Histopathology Induced in F344 Rats in Subchronic Toxicity and Carcinogenicity Studies with Tetrahydrofuran","author":"Hard","year":"2005"},{"key":"10.1016\/j.yrtph.2019.104499_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/01926230490422574","article-title":"A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment","volume":"32","author":"Hard","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104499_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/01926230500299716","article-title":"Recommendations for the interpretation of renal tubule proliferative lesions occurring in rat kidneys with advanced chronic progressive nephropathy (CPN)","volume":"33","author":"Hard","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104499_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/01926230601083381","article-title":"Histological investigation of diagnostically challenging tubule profiles in advanced chronic progressive nephropathy (CPN) in the fischer 344 RaT","volume":"34","author":"Hard","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104499_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/019262339702500202","article-title":"Relationship of hydroquinone-associated rat renal tumors with spontaneous chronic progressive nephropathy","volume":"25","author":"Hard","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104499_bib39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.fct.2006.10.018","article-title":"Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercetin","volume":"45","author":"Hard","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/10408440802368642","article-title":"A comparison of rat chronic progressive nephropathy with human renal disease-implications for human risk assessment","volume":"39","author":"Hard","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.yrtph.2011.01.007","article-title":"Renal histopathology in toxicity and carcinogenicity studies with tert-butyl alcohol administered in drinking water to F344 rats: a pathology working group review and re-evaluation","volume":"59","author":"Hard","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/toxsci\/kfs305","article-title":"Consideration of rat chronic progressive nephropathy in regulatory evaluations for carcinogenicity","volume":"132","author":"Hard","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2019.104499_bib3","series-title":"Health Council of the Netherlands. Tetrahydrofuran. Evaluation of the Carcinogenicity and Genotoxicity","isbn-type":"print","year":"2012","ISBN":"https:\/\/id.crossref.org\/isbn\/9789055499168"},{"key":"10.1016\/j.yrtph.2019.104499_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/tx060033d","article-title":"2'-deoxyguanosine, 2'-deoxycytidine, and 2'-deoxyadenosine adducts resulting from the reaction of tetrahydrofuran with DNA bases","volume":"19","author":"Hermida","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib44","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.yrtph.2019.104499_bib46","series-title":"Some Chemicals that Cause Tumours of the Urinary Tract in Rodents","author":"IARC-Monographs","year":"2019"},{"key":"10.1016\/j.yrtph.2019.104499_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/030098588902600102","article-title":"Increased levels of DNA synthesis in hyperplastic renal tubules of aging nephropathy in female F344\/NCr rats","volume":"26","author":"Konishi","year":"1989","journal-title":"Vet Pathol"},{"key":"10.1016\/j.yrtph.2019.104499_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/10408440490265210","article-title":"Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI\/NTP database and categorization of renal carcinogens based on mechanistic information","volume":"34","author":"Lock","year":"2004","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/tx0497494","article-title":"Structural characterization of an etheno-2'-deoxyguanosine adduct modified by tetrahydrofuran","volume":"18","author":"Loureiro","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib50","series-title":"Deutsche Forschungsgemeinschaft, Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area: Tetrahydrofuran; Series: MAK Value Documentation","year":"2004"},{"key":"10.1016\/j.yrtph.2019.104499_bib51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yrtph.2013.03.012","article-title":"A framework for fit-for-purpose dose response assessment","volume":"66","author":"Meek","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jat.2984","article-title":"Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib54","volume":"vol. 475","year":"1998"},{"key":"10.1016\/j.yrtph.2019.104499_bib55","series-title":"\u201cUsers' Handbook Supplement to the Guidance Document for Developing and Assessing 1076 Adverse Outcome Pathways\u201d, OECD Series on Adverse Outcome Pathways, No. 1","year":"2016"},{"key":"10.1016\/j.yrtph.2019.104499_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/toxsci\/kfr191","article-title":"Multi-species analyses of direct activators of the constitutive androstane receptor","volume":"123","author":"Omiecinski","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2019.104499_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yrtph.2012.12.008","article-title":"Use and validation of HT\/HC assays to support 21st century toxicity evaluations","volume":"65","author":"Patlewicz","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yrtph.2018.04.001","article-title":"Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors","volume":"96","author":"Peffer","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/taap.1999.8661","article-title":"Evaluation of the in vivo interaction of methyl tert-butyl ether with alpha2u-globulin in male F-344 rats","volume":"157","author":"Prescott-Mathews","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/019262339802600109","article-title":"Chemically induced glomerular injury: a review of basic mechanisms and specific xenobiotics","volume":"26","author":"Robertson","year":"1998","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.104499_bib61","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0041-008X(89)90191-9","article-title":"Elevated proliferation of proximal tubule cells and localization of accumulated alpha 2u-globulin in F344 rats during chronic exposure to unleaded gasoline or 2,2,4-trimethylpentane","volume":"101","author":"Short","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/taap.1995.1007","article-title":"Renal tumorigenicity of 1,1-dichloroethene in mice: the role of male specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene","volume":"130","author":"Speerschneider","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib63","series-title":"Alpha 2-Urinary Globulin-Associated Nephropathy as a Mechanism of Renal Tubule Cell Carcinogenesis in Male Rats","first-page":"95","author":"Swenberg","year":"1999"},{"key":"10.1016\/j.yrtph.2019.104499_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0041-008X(89)90053-7","article-title":"The comparative pathobiology of alpha 2u-globulin nephropathy","volume":"97","author":"Swenberg","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104499_bib65","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s002040050500","article-title":"Oxidative DNA damage and cell proliferation in kidneys of male and female rats during 13-weeks exposure to potassium bromate (KBrO3)","volume":"72","author":"Umemura","year":"1998","journal-title":"Arch. Toxicol."},{"issue":"Suppl. 5","key":"10.1016\/j.yrtph.2019.104499_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2014.967836","article-title":"Effects of atrazine in fish, amphibians, and reptiles: an analysis based on quantitative weight of evidence","volume":"44","author":"Van Der Kraak","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00204-003-0474-7","article-title":"Effect of cytochrome P-450 inhibition on tetrahydrofuran-induced hepatocellular proliferation in female mice","volume":"77","author":"van Ravenzwaay","year":"2003","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2019.104499_bib68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/019262339802600602","article-title":"Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats","volume":"26","author":"Wolf","year":"1998","journal-title":"Toxicol. Pathol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019302636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019302636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:28:48Z","timestamp":1759494528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019302636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":67,"alternative-id":["S0273230019302636"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104499","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrahydrofuran-induced tumors in rodents are not relevant to humans: Quantitative weight of evidence analysis of mode of action information does not support classification of tetrahydrofuran as a possible human carcinogen","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104499"}}